Skip to content

Florida shipping only this week. All states soon. Sign up for updates →

BPC-157 compounded vial

// Peptides

BPC-157

Body Protection Compound — supports tendon, ligament, and gut healing.

  • Studied for tendon, ligament, and gut tissue repair
  • Often paired with TB-500 for comprehensive recovery
  • Compounded under USP 797 sterile standards
  • Third-party tested for potency and purity

Starting from

Sign-in required. A licensed physician reviews every prescription before it ships.

Read the full protocol ↓

// All formulations

2 formulations available

For orientation only — your physician confirms the final protocol on the pharmacy storefront.

OptionSizePrice
Standard injectable5 mL vial$109
High-concentration injectable5 mL vial$155

Compounded by Greenstone Rx · Florida 503A pharmacy

Continue to Pharmacy →

// The science

About BPC-157

BPC-157 is a synthetic peptide derived from a protein found in gastric juice. Preclinical research suggests it accelerates tendon, ligament, and gut tissue repair via angiogenesis, growth factor upregulation, and nitric oxide modulation. Often paired with TB-500 in comprehensive recovery protocols.

// How it works

How it works

BPC-157 is a synthetic peptide derived from a protein in gastric juice. It promotes new blood vessel formation (angiogenesis), reduces inflammation, and accelerates healing of soft-tissue injuries — particularly tendons and ligaments that heal slowly because of poor blood supply.

// Who it's for

Who it's for

Patients with chronic tendinopathies (Achilles, tennis elbow, rotator cuff). Post-surgical recovery. GI inflammation that hasn't resolved with conventional treatment. Athletes managing recurring soft-tissue strains.

// What to expect

Your timeline

  1. First 1–2 weeks

    Sometimes a brief flare in inflamed tissue — the repair process is being activated. Then steady reduction in pain and improvement in range of motion.

  2. Weeks 4–8

    Most patients report meaningful improvement by this point. Pair with physical therapy for best results.

// Who should not take this

Who should not take this

Active cancer (the same vessel-growth signaling could theoretically support tumor growth — discuss with provider). Pregnancy.

// Typical starting dose

Typical starting dose

A typical starting protocol is 500 mcg subcutaneous injection daily (≈43 mcg/kg/week, adjusted for body weight). Your physician will adjust on review. Suggestions only — your physician reviews and approves the final protocol before any medication ships.

// Ready when you are

Start your prescription.

You'll complete a short health screening on the pharmacy storefront. A licensed physician reviews every order before any medication ships.

Continue to Pharmacy →

Compounded by a 503A licensed pharmacy pursuant to a valid prescription. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Full disclaimer.